| MeSH term | MeSH ID | Detail |
|---|---|---|
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pulmonary Fibrosis | D011658 | 24 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Reperfusion Injury | D015427 | 65 associated lipids |
| Colitis | D003092 | 69 associated lipids |
DHA
Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.
Cross Reference
Introduction
To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with DHA?
DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with DHA
PubChem Associated disorders and diseases
What pathways are associated with DHA
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with DHA?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with DHA?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with DHA?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with DHA?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with DHA?
Mouse Model
Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).
Transgenic Model
Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).
Animal Disease Models
Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with DHA
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Reynolds LM et al. | Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. | 2001 | Neurosci. Lett. | pmid:11514074 |
| Gazzah N et al. | Evidence for brain docosahexaenoate recycling in the free-moving adult rat: implications for measurement of phospholipid synthesis. | 1994 | Neurosci. Lett. | pmid:7824158 |
| Wang X et al. | Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. | 2003 | Neuroreport | pmid:14663210 |
| Wu A et al. | Dietary strategy to repair plasma membrane after brain trauma: implications for plasticity and cognition. | 2014 | Neurorehabil Neural Repair | pmid:23911971 |
| Baldessarini RJ et al. | Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat. | 2001 | Neuropsychopharmacology | pmid:11106876 |
| Ethier I et al. | The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. | 2004 | Neuropsychopharmacology | pmid:14603264 |
| Lu DY et al. | Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids. | 2010 | Neuropsychopharmacology | pmid:20668435 |
| Molloy C et al. | Docosahexaenoic acid and visual functioning in preterm infants: a review. | 2012 | Neuropsychol Rev | pmid:23065239 |
| Tamim MK et al. | Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. | 2010 | Neuropharmacology | pmid:19576910 |
| Poling JS et al. | Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc. | 1996 | Neuropharmacology | pmid:8938727 |
| Bate C et al. | Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. | 2008 | Neuropharmacology | pmid:18355880 |
| Li Z et al. | Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. | 2006 | Neuropharmacology | pmid:16895729 |
| Suganuma H et al. | Maternal docosahexaenoic acid-enriched diet prevents neonatal brain injury. | 2010 | Neuropathology | pmid:20408962 |
| Zhao Z and Zlokovic BV | Blood-brain barrier: a dual life of MFSD2A? | 2014 | Neuron | pmid:24853933 |
| Mucke L and Pitas RE | Food for thought: essential fatty acid protects against neuronal deficits in transgenic mouse model of AD. | 2004 | Neuron | pmid:15339638 |
| Calon F et al. | Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. | 2004 | Neuron | pmid:15339646 |
| Dyall SC and Michael-Titus AT | Neurological benefits of omega-3 fatty acids. | 2008 | Neuromolecular Med. | pmid:18543124 |
| Ammann EM et al. | ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. | 2013 | Neurology | pmid:24068783 |
| Martinez M and Vazquez E | MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. | 1998 | Neurology | pmid:9674774 |
| MartÃnez M | Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? | 1990 | Neurology | pmid:2143272 |
| Pottala JV et al. | Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. | 2014 | Neurology | pmid:24453077 |
| Paker AM et al. | Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. | 2010 | Neurology | pmid:20805528 |
| Martinez M et al. | Docosahexaenoic acid--a new therapeutic approach to peroxisomal-disorder patients: experience with two cases. | 1993 | Neurology | pmid:8327143 |
| Ajami M et al. | Expression of Bcl-2 and Bax after hippocampal ischemia in DHA + EPA treated rats. | 2011 | Neurol. Sci. | pmid:21617951 |
| Narita K et al. | Therapeutic time window in the penumbra during permanent focal ischemia in rats: changes of free fatty acids and glycerophospholipids. | 2000 | Neurol. Res. | pmid:10874689 |
| Jones CR et al. | Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. | 1997 | Neurochem. Res. | pmid:9178948 |
| Ikemoto A et al. | Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. | 1997 | Neurochem. Res. | pmid:9178949 |
| Halapin NA and Bazan NG | NPD1 induction of retinal pigment epithelial cell survival involves PI3K/Akt phosphorylation signaling. | 2010 | Neurochem. Res. | pmid:21136150 |
| Lee HJ et al. | Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. | 2005 | Neurochem. Res. | pmid:16176072 |
| Prasad MR et al. | Regional membrane phospholipid alterations in Alzheimer's disease. | 1998 | Neurochem. Res. | pmid:9482271 |
| Chang MC et al. | Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. | 1999 | Neurochem. Res. | pmid:10215514 |
| Machová E et al. | The increase of choline acetyltransferase activity by docosahexaenoic acid in NG108-15 cells grown in serum-free medium is independent of its effect on cell growth. | 2006 | Neurochem. Res. | pmid:17004129 |
| Alvarez-Nölting R et al. | Protection by DHA of early hippocampal changes in diabetes: possible role of CREB and NF-κB. | 2012 | Neurochem. Res. | pmid:21909958 |
| Orr SK et al. | The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. | 2010 | Neurochem. Res. | pmid:20177777 |
| Brown J et al. | Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA). | 2009 | Neurochem. Res. | pmid:18592376 |
| Kabuto H et al. | Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. | 2009 | Neurochem. Res. | pmid:19219632 |
| de Turco EB et al. | Strong association of unesterified [3H]docosahexaenoic acid and [3H-docosahexaenoyl]phosphatidate to rhodopsin during in vivo labeling of frog retinal rod outer segments. | 2000 | Neurochem. Res. | pmid:10905632 |
| Martin RE et al. | Uptake and incorporation of docosahexaenoic acid (DHA) into neuronal cell body and neurite/nerve growth cone lipids: evidence of compartmental DHA metabolism in nerve growth factor-differentiated PC12 cells. | 2000 | Neurochem. Res. | pmid:10905634 |
| Terrian DM et al. | Glutamate is the endogenous amino acid selectively released by rat hippocampal mossy fiber synaptosomes concomitantly with prodynorphin-derived peptides. | 1990 | Neurochem. Res. | pmid:1970130 |
| Dagai L et al. | Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth. | 2009 | Neurochem. Res. | pmid:18781386 |
| Hashimoto M et al. | Prescription n-3 fatty acids, but not eicosapentaenoic acid alone, improve reference memory-related learning ability by increasing brain-derived neurotrophic factor levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. | 2013 | Neurochem. Res. | pmid:23963508 |
| Fraser T et al. | Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. | 2010 | Neurochem. Res. | pmid:19904605 |
| Petroni A et al. | Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells. | 1994 | Neurochem. Res. | pmid:7824073 |
| Giesing M and Zilliken F | Lipid metabolism of developing central nervous tissues in organotypic cultures. III. Ganglionic control of glycerolipids and fatty acids in cortex grey matter. | 1980 | Neurochem. Res. | pmid:6445512 |
| Schonfeld E et al. | Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells. | 2007 | Neurochem. Res. | pmid:17551831 |
| Ouellet M et al. | Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. | 2009 | Neurochem. Int. | pmid:19442696 |
| Ozsoy O et al. | The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease. | 2011 | Neurochem. Int. | pmid:21736911 |
| Cieslik M et al. | Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment. | 2013 | Neurochem. Int. | pmid:23439385 |
| Julien C et al. | Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. | 2006 | Neurochem. Int. | pmid:16442670 |
| Grintal B et al. | Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. | 2009 | Neurochem. Int. | pmid:19428799 |
| Boudrault C et al. | Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice. | 2010 | Neurochem. Int. | pmid:20064570 |
| Rosenberger TA et al. | Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. | 2010 | Neurochem. Int. | pmid:20026368 |
| Mathieu G et al. | DHA enhances the noradrenaline release by SH-SY5Y cells. | 2010 | Neurochem. Int. | pmid:19770016 |
| Mahmoudi S et al. | Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid. | 2009 | Neurobiol. Dis. | pmid:19635563 |
| De Felice C et al. | Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. | 2014 | Neurobiol. Dis. | pmid:24769161 |
| Hooijmans CR et al. | Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). | 2007 | Neurobiol. Dis. | pmid:17720508 |
| Hooijmans CR et al. | DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. | 2009 | Neurobiol. Dis. | pmid:19130883 |
| Eady TN et al. | Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats. | 2014 | Neurobiol. Dis. | pmid:24063996 |
| Oksman M et al. | Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. | 2006 | Neurobiol. Dis. | pmid:16765602 |
| Norris SE et al. | Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease. | 2015 | Neurobiol. Aging | pmid:25676385 |
| Favrelère S et al. | Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. | 2000 Sep-Oct | Neurobiol. Aging | pmid:11016534 |
| Stough C et al. | The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. | 2012 | Neurobiol. Aging | pmid:21531481 |
| Robson LG et al. | Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. | 2010 | Neurobiol. Aging | pmid:18620782 |
| Wang DC et al. | Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. | 2012 | Neurobiol. Aging | pmid:20980076 |
| Walhovd KB et al. | Blood markers of fatty acids and vitamin D, cardiovascular measures, body mass index, and physical activity relate to longitudinal cortical thinning in normal aging. | 2014 | Neurobiol. Aging | pmid:24332985 |
| Favrelière S et al. | DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. | 2003 Mar-Apr | Neurobiol. Aging | pmid:12498957 |
| Marin R et al. | Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases. | 2017 | Neurobiol. Aging | pmid:27768960 |
| Hacioglu G et al. | Beneficial effects of docosahexaenoic acid on active avoidance performance in 1K-1C hypertensive rats. | 2007 | Neurobiol Learn Mem | pmid:16979916 |
| Vasickova L et al. | Possible effect of DHA intake on body weight reduction and lipid metabolism in obese children. | 2011 | Neuro Endocrinol. Lett. | pmid:22101886 |
| Mincke E et al. | Lower omega-3 polyunsaturated fatty acids and lower docosahexaenoic acid in men with pedophilia. | 2006 | Neuro Endocrinol. Lett. | pmid:17187003 |
| Maes M et al. | Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response. | 2007 | Neuro Endocrinol. Lett. | pmid:18063921 |
| Mraz J et al. | Culture of common carp (Cyprinus carpio) with defined flesh quality for prevention of cardiovascular diseases using finishing feeding strategy. | 2012 | Neuro Endocrinol. Lett. | pmid:23183512 |
| Sliwinski S et al. | Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? | 2006 | Neuro Endocrinol. Lett. | pmid:16891996 |
| Turck D | Later effects of breastfeeding practice: the evidence. | 2007 | Nestle Nutr Workshop Ser Pediatr Program | pmid:17664895 |
| Michaelsen KF et al. | Whole cow's milk: why, what and when? | 2007 | Nestle Nutr Workshop Ser Pediatr Program | pmid:17664906 |
| Makrides M et al. | Role of long-chain polyunsaturated fatty acids in neurodevelopment and growth. | 2010 | Nestle Nutr Workshop Ser Pediatr Program | pmid:20139678 |
| Bazan NG et al. | Docosahexaenoic acid and its derivative neuroprotectin D1 display neuroprotective properties in the retina, brain and central nervous system. | 2013 | Nestle Nutr Inst Workshop Ser | pmid:24107502 |
| Scholtz SA et al. | Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period. | 2013 | Nestle Nutr Inst Workshop Ser | pmid:24107504 |
| Rylance PB et al. | Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. | 1986 | Nephron | pmid:3724927 |
| Beavers KM et al. | Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients. | 2008 | Nephrology (Carlton) | pmid:18331436 |
| Huang X et al. | Serum and adipose tissue fatty acid composition as biomarkers of habitual dietary fat intake in elderly men with chronic kidney disease. | 2014 | Nephrol. Dial. Transplant. | pmid:23229929 |
| Saifullah A et al. | Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. | 2007 | Nephrol. Dial. Transplant. | pmid:17623719 |
| Ferraro PM et al. | Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. | 2009 | Nephrol. Dial. Transplant. | pmid:18685141 |
| Chin HJ et al. | Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. | 2010 | Nephrol. Dial. Transplant. | pmid:20042400 |
| Cheng IK et al. | The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis. | 1990 | Nephrol. Dial. Transplant. | pmid:2113220 |
| van Acker BA et al. | The effect of fish oil on lipid profile and viscosity of erythrocyte suspensions in CAPD patients. | 1987 | Nephrol. Dial. Transplant. | pmid:2831474 |
| Hu Y et al. | Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. | 2010 | Neoplasia | pmid:20927321 |
| Lapillonne A et al. | Postnatal docosahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants. | 2010 | Neonatology | pmid:21051909 |
| Berman DR et al. | Docosahexaenoic acid augments hypothermic neuroprotection in a neonatal rat asphyxia model. | 2013 | Neonatology | pmid:23817197 |
| Docosahexaenoic and arachidonic acid levels in ELBW infants with prolonged exposure to intravenous lipids. | 2013 May-Jun | Neonatal Netw | pmid:23807965 | |
| Mitmesser SH and Jensen CL | Roles of long-chain polyunsaturated fatty acids in the term infant: developmental benefits. | 2007 Jul-Aug | Neonatal Netw | pmid:17710956 |
| Korstanje MJ et al. | [Fish oil; from food to medicine?]. | 1991 | Ned Tijdschr Geneeskd | pmid:1828538 |
| Gavzan H et al. | Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models. | 2015 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:26018398 |
| Reithmann C et al. | Exposure to the n-3 polyunsaturated fatty acid docosahexaenoic acid impairs alpha 1-adrenoceptor-mediated contractile responses and inositol phosphate formation in rat cardiomyocytes. | 1996 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:8857587 |
| Itoh T and Yamamoto K | Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand. | 2008 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:18193404 |
| Dhein S et al. | Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. | 2005 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:15900514 |
| Turner N et al. | Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism. | 2003 | Naturwissenschaften | pmid:14610651 |
| Serhan CN | Pro-resolving lipid mediators are leads for resolution physiology. | 2014 | Nature | pmid:24899309 |
| Swinbanks D | Fish-oil miracle additive brings benefits to some. | 1993 | Nature | pmid:8321302 |
| Chiang N et al. | Infection regulates pro-resolving mediators that lower antibiotic requirements. | 2012 | Nature | pmid:22538616 |